Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IMPACT
- Development stage
- Phase 4
- Lead developer
- Nestlé Health Science
- Modality
- Small Molecules, Peptides
- Administration
- Oral
01
Overview
IMPACT is an immunomodulating oral nutritional supplement (ONS) produced by Nestlé Health Science, specifically formulated as a medical food for the dietary management of patients undergoing major surgery or facing clinical challenges like trauma or burns. The formula contains a unique blend of immunonutrients, including arginine, glutamine, omega-3 fatty acids (eicosapentaenoic acid and docosahexaenoic acid), nucleotides, and antioxidants (vitamins C and E). These components work synergistically to modulate the immune response, reduce systemic inflammation, and support tissue repair and protein synthesis. In clinical settings, such as the Phase 4 trials conducted at Stanley Dudrick's Memorial Hospital, IMPACT is administered preoperatively to patients with gastrointestinal cancer to reduce the incidence of postoperative infectious complications and decrease the length of hospital stay.
- Brand names
- IMPACT
- Other names
- Immunoenhancing ONSImmunomodulating oral nutritional supplement
02
Targets
FFAR4 (Free fatty acid receptor 4)FFAR1 (Free fatty acid receptor 1)PPARA (Peroxisome proliferator-activated receptor alpha)PPARG (Peroxisome proliferator-activated receptor gamma)
Beyond the preview
Go deeper on IMPACT.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IMPACT.